Glenmark Infringed Bayer's Finacea Patent, Judge Rules
A Delaware federal judge ruled Monday that Glenmark Pharmaceuticals Ltd. infringed a Bayer Healthcare Pharmaceuticals Inc. patent for its Finacea rosacea treatment, saying the Mumbai-based pharmaceutical company also failed to show...To view the full article, register now.
Already a subscriber? Click here to view full article